161 related articles for article (PubMed ID: 27048780)
21. Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1.
Tan LG; Tan YK; Tai BC; Tan KM; Gauhar V; Tiong HY; Hawkins RC; Thamboo TP; Hong FS; Chiong E
Asian J Androl; 2017; 19(3):286-290. PubMed ID: 26908062
[TBL] [Abstract][Full Text] [Related]
22. Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience.
Al Saidi SS; Al Riyami NB; Al Marhoon MS; Al Saraf MS; Al Busaidi SS; Bayoumi R; Mula-Abed WS
Oman Med J; 2017 Jul; 32(4):275-283. PubMed ID: 28804579
[TBL] [Abstract][Full Text] [Related]
23. Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL.
Ferro M; Crocetto F; La Civita E; Fiorenza M; Jannuzzi G; Carbone G; Sirica R; Sicignano E; Pagano G; Imbimbo C; Terracciano D
Prostate; 2024 May; ():. PubMed ID: 38798011
[TBL] [Abstract][Full Text] [Related]
24. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.
Chiu PK; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF
Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315
[TBL] [Abstract][Full Text] [Related]
25. p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study.
Casale P; Saita A; Lazzeri M; Lughezzani G; Hurle R; Fasulo V; Mondellini GM; Paciotti M; Domanico L; Lista G; Maffei D; Monari M; Motta L; Bini V; Ceriotti F; Guazzoni G; Buffi NM
Minerva Urol Nefrol; 2019 Jun; 71(3):273-279. PubMed ID: 30700081
[TBL] [Abstract][Full Text] [Related]
26. Prostate health index density predicts aggressive pathological outcomes after radical prostatectomy in Taiwanese patients.
Huang YP; Lin TP; Cheng WM; Wei TC; Huang IS; Fan YH; Lin CC; Huang EYH; Chung HJ; Kuo JY; Wu HHH; Lu SH; Chang YH; Lin ATL; Huang WJS
J Chin Med Assoc; 2019 Nov; 82(11):835-839. PubMed ID: 31425303
[TBL] [Abstract][Full Text] [Related]
27. The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years.
Boegemann M; Stephan C; Cammann H; Vincendeau S; Houlgatte A; Jung K; Blanchet JS; Semjonow A
BJU Int; 2016 Jan; 117(1):72-9. PubMed ID: 25818705
[TBL] [Abstract][Full Text] [Related]
28. Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy.
Eminaga O; Bögemann M; Breil B; Titze U; Wötzel F; Eltze E; Bettendorf O; Semjonow A
Urol Oncol; 2014 Nov; 32(8):1317-26. PubMed ID: 24893699
[TBL] [Abstract][Full Text] [Related]
29. Establishment of reference intervals for serum [-2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men.
Wu ZY; Yang C; Luo J; Deng SL; Wu B; Chen M
Onco Targets Ther; 2019; 12():6453-6460. PubMed ID: 31616156
[TBL] [Abstract][Full Text] [Related]
30. The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10 μg/L.
Filella X; Foj L; Alcover J; Augé JM; Molina R; Jiménez W
Clin Chim Acta; 2014 Sep; 436():303-7. PubMed ID: 24978824
[TBL] [Abstract][Full Text] [Related]
31. Measurement of serum isoform [-2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2-10 ng/ml.
Furuya K; Kawahara T; Narahara M; Tokita T; Fukui S; Imano M; Mitome T; Ito Y; Izumi K; Osaka K; Yokomizo Y; Hayashi N; Hasumi H; Nawata S; Kawano T; Yao M; Uemura H
Scand J Urol; 2017 Aug; 51(4):251-257. PubMed ID: 28351193
[TBL] [Abstract][Full Text] [Related]
32. Prostate Health Index and %p2PSA Predict Aggressive Prostate Cancer Pathology in Chinese Patients Undergoing Radical Prostatectomy.
Chiu PK; Lai FM; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF
Ann Surg Oncol; 2016 Aug; 23(8):2707-14. PubMed ID: 26965697
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range.
Ito K; Miyakubo M; Sekine Y; Koike H; Matsui H; Shibata Y; Suzuki K
World J Urol; 2013 Apr; 31(2):305-11. PubMed ID: 22903772
[TBL] [Abstract][Full Text] [Related]
34. The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.
Ng CF; Chiu PK; Lam NY; Lam HC; Lee KW; Hou SS
Int Urol Nephrol; 2014 Apr; 46(4):711-7. PubMed ID: 24136184
[TBL] [Abstract][Full Text] [Related]
35. Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer.
Raju GNL; Bhat PP; Nagini S
J Lab Physicians; 2023 Jun; 15(2):237-242. PubMed ID: 37323608
[No Abstract] [Full Text] [Related]
36. Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.
Abrate A; Lughezzani G; Gadda GM; Lista G; Kinzikeeva E; Fossati N; Larcher A; Dell'Oglio P; Mistretta F; Buffi N; Guazzoni G; Lazzeri M
Korean J Urol; 2014 Jul; 55(7):436-45. PubMed ID: 25045441
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of prostate health index to identify aggressive prostate cancer. An Institutional validation study.
Morote J; Celma A; Planas J; Placer J; Ferrer R; de Torres I; Pacciuci R; Olivan M
Actas Urol Esp; 2016; 40(6):378-85. PubMed ID: 26923032
[TBL] [Abstract][Full Text] [Related]
38. Prostate health index (PHI) as an accurate prostate cancer predictor.
Yáñez-Castillo YM; Melgarejo-Segura MT; Funes-Padilla C; Folgueral-Corral ME; García-Larios JV; Arrabal-Polo MA; De Haro Muñoz T; Arrabal-Martín M
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9329-9335. PubMed ID: 37204514
[TBL] [Abstract][Full Text] [Related]
39. Preanalytical stability of molecular forms of prostate-specific antigen in serum samples (PSA, free PSA, [-2]proPSA) and their impact on fPSA/tPSA ratio and PHI.
Šimánek V; Vrzáková R; Viták R; Jirásko M; Fürst T; Topolčan O; Pecen L; Vurm V; Kučera R
Prostate; 2024 May; 84(7):656-665. PubMed ID: 38414098
[TBL] [Abstract][Full Text] [Related]
40. Prostate health index is useful for prostate cancer detecting in Chinese people.
Huang Y; Gu X; Wang Y; Hou J; Qi X
Transl Cancer Res; 2019 Jun; 8(3):836-839. PubMed ID: 35116822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
